Lu-177-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney

Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Christiane Schuchardt, Karin Niepsch, Thomas Langbein, Richard P. Baum*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1579-1586
Number of pages8
JournalJournal of Nuclear Medicine
Volume60
Issue number11
DOIs
Publication statusPublished - 1 Nov 2019

Keywords

  • prostate-specific membrane antigen
  • radioligand therapy
  • single functioning kidney
  • Lu-177
  • renal toxicity
  • TARGETED RADIONUCLIDE THERAPY
  • PSMA INHIBITOR
  • LIGANDS
  • EXPRESSION
  • CRITERIA
  • RECIST
  • SAMPLE
  • TUMORS

Cite this